BioAge Labs (BIOA) Long-Term Debt Issuances (2024 - 2026)

BioAge Labs has disclosed Long-Term Debt Issuances across 3 years of filings, most recently posting $500000.0 for Q2 2026.

• In Q2 2026, Long-Term Debt Issuances fell 66.67% year-over-year to $500000.0; the TTM figure through Jun 2026 stood at $5.0 million (down 16.67% YoY), while the FY2025 annual figure was $6.0 million, changed 0.0% from the prior year.
• Long-Term Debt Issuances came in at $500000.0 for Q2 2026 at BioAge Labs, down from $1.5 million in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $1.5 million in Q1 2024 to a low of $500000.0 in Q2 2026.
• Average Long-Term Debt Issuances over 3 years is $1.4 million, with a median of $1.5 million recorded in 2024.
• Year-over-year, Long-Term Debt Issuances changed 0.0% in 2025 and plunged 66.67% in 2026.
• Over 3 years, Long-Term Debt Issuances stood at $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then plunged by 66.67% to $500000.0 in 2026.
• Per Business Quant data, the three most recent Long-Term Debt Issuances figures were $500000.0 in Q2 2026, $1.5 million in Q1 2026, and $1.5 million in Q4 2025.